ASND
Ascendis Pharma AS
227.80$
-0.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.83 | 0.34 | 0.17 | 0.05 | 0.26 | 0.29 | 0.14 | 0.14 | 0.91 | 4.74 | 6.28 | 11.41 | |
| 2.20 | 1,474,818,544.54 | 249,940.27 | 29,738,622,783.56 | 0.00 | 0.00 | 0.00 | 0.06 | 0.22 | 0.79 | 0.76 | 1.70 | |
| 0.83 | 0.34 | 0.17 | 0.05 | 0.26 | 0.29 | 0.14 | 0.08 | 0.70 | 3.95 | 5.52 | 9.71 | |
| 1.16 | 1.71 | 2.49 | 2.96 | 3.41 | 4.12 | 5.15 | 5.40 | 6.77 | 7.35 | 5.30 | 4.68 | |
| 0.37 | 0.40 | 0.43 | 0.40 | 0.61 | 1.04 | 1.51 | 2.92 | 3.85 | 4.60 | 4.92 | 7.39 | |
| 1.53 | 2.10 | 2.92 | 3.36 | 4.02 | 5.16 | 6.67 | 8.33 | 10.72 | 12.04 | 10.33 | 11.87 | |
| -0.71 | -1.76 | -2.75 | -3.32 | -3.77 | -4.87 | -6.53 | -8.25 | -10.02 | -8.09 | -4.82 | -2.16 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 | 0.07 | 0.55 | 0.78 | 1.13 | 1.28 | |
| -0.61 | -1.41 | -2.59 | -3.70 | -3.18 | -4.69 | -8.28 | -7.01 | -10.30 | -8.42 | -6.45 | -3.37 | |
| -0.04 | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | 0.10 | 0.13 | 0.08 | 0.24 | |
| -0.57 | -1.39 | -2.58 | -3.68 | -3.17 | -4.69 | -8.28 | -7.00 | -10.40 | -8.55 | -6.53 | -3.61 | |
| -0.68 | -1.39 | -2.71 | -3.27 | -3.66 | -4.52 | -8.06 | -6.66 | -9.44 | -7.30 | -5.01 | -1.81 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.